President Trump announced Thursday a deal with Eli Lilly and Novo Nordisk to reduce prices for popular weight loss drugs for some Americans. CBS News' Aaron Navarro has more.
Breakdown
- President Trump announced partnerships with Eli Lilly and Novo Nordisk to lower weight loss drug prices. 10s
- The deal will reduce monthly costs for drugs like Ozempic and Wegovy to as low as $245, with a $50 copay for some Medicare recipients. 1m 15s
- Lower prices are expected to begin in May 2026, with a direct-to-consumer option available for $350 via a new platform called Trump Rx. 1m 45s
- In exchange, drug companies will gain access to more patients, tariff certainty, and priority FDA review. 2m 3s
- The press conference ended abruptly after a company representative fainted, but the individual is reported to be okay. 2m 23s